2 results match your criteria: "Departments of Urology and Brady Urological Institute[Affiliation]"
Oligometastatic prostate cancer to the navicular bone: case report.
Urol Case Rep
May 2015
Departments of Urology and Brady Urological Institute, and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD, 21287 ; Departments of Pharmacology and Molecular Sciences, and Chemical and Biomolecular Engineering, The Johns Hopkins Medical Institutions, Baltimore, MD, 21287.
Article Synopsis
- This case illustrates that unexplained symptoms in patients with a primary cancer, like prostate cancer, should consider metastasis, even if the presentation is unusual.
- It emphasizes the need to compare new imaging studies with previous baseline images to detect subtle changes that may reveal metastasis over time.
- The case serves as a reminder for healthcare professionals to keep an open mind regarding potential metastatic developments in atypical cases.
The biology and treatment of oligometastatic cancer.
Oncotarget
April 2015
Departments of Urology and Brady Urological Institute and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD, 21287, USA.
Article Synopsis
- Oligometastasis refers to a state where cancer metastases are limited and treatable, existing between localized and widespread disease.
- If the primary tumor is controlled or removed, and the metastases are treated effectively, patients may experience longer disease-free intervals or even a potential cure.
- Advances in molecular diagnostics and improved imaging techniques are helping to identify patients with oligometastatic disease, leading to novel treatment options and broader definitions for this condition.